| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2883688 | The Annals of Thoracic Surgery | 2006 | 8 Pages |
Abstract
Protamine enhanced fibrinolysis by decreasing clot strength by diminishing TF-initiated thrombin generation. Additional, clinical investigation is warranted to mechanistically implicate protamine-mediated enhancement of fibrinolysis to delayed bleeding after cardiopulmonary bypass.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Vance G. MD,